SAHEL Jose-Alain;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE;INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE);VIDAL Cecile;SORBONNE UNIVERSITE;FONTAINE Valerie
发明人:
FONTAINE Valerie,VIDAL Cecile,SAHEL Jose-Alain
申请号：
IL25938118
公开号：
IL259381D0
申请日:
2018.05.15
申请国别(地区):
IL
年份:
2018
代理人:
摘要：
Disclosed is a method utilizing (R)-2-(2-aminothiazol-4-yl)-4′-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide or an analogue, pharmaceutically acceptable salt or solvate thereof for the treatment of a retinal disease, more specifically using mirabegron for the treatment of age-related macular degeneration. Also Disclosed is a pharmaceutical composition, a medicament and a kit for the treatment of age-related macular degeneration.
